| Bioactivity | HPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2018102366A1 compound I-47[1]. | ||||||||||||
| Target | hematopoietic progenitor kinase 1 (HPK1) | ||||||||||||
| Name | HPK1-IN-19 | ||||||||||||
| CAS | 2227609-33-6 | ||||||||||||
| Formula | C27H32N7O2P | ||||||||||||
| Molar Mass | 517.56 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Huang WS, et, al. Anilinopyrimidines as haematopoietic progenitor kinase 1 (hpk1) inhibitors. WO2018102366A1. |
HPK1-IN-19
CAS: 2227609-33-6 F: C27H32N7O2P W: 517.56
HPK1-IN-19 is a hematopoietic progenitor kinase 1 (HPK1) inhibitor extracted from patent WO2018102366A1 compound I-47.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.